|
CoreLab Partners’ proven medical imaging services, coupled with cutting edge technologies and regulatory expertise, successfully facilitates drug development programs of global and domestic bio-pharmaceutical and medical device organizations – large and small.
Our best-in-class imaging solutions bring efficiencies to early stage clinical through phase IV studies, utilizing all major modalities, across all major therapeutic areas. In fact, CoreLab Partners’ proven central imaging review services have been employed across almost 500 clinical trials, including the successful development of 16 of the last 17 approved cancer drugs/devices.
CoreLab Partners independent review and medical imaging management services saves you time and scarce resources by providing accurate, credible data sooner - thereby enabling quicker decision-making. Whether you need to make a go/no go decision during early clinical stages or are submitting Phase III trial results to the FDA, we provide the crucial necessary data and expertise when you need it most.
Our services include:
|